Robot | Path | Permission |
GoogleBot | / | ✔ |
BingBot | / | ✔ |
BaiduSpider | / | ✔ |
YandexBot | / | ✔ |
Title | N/A |
Description | N/A |
Keywords | N/A |
WebSite | www.elybiotech.com |
Host IP | N/A |
Location | N/A |
Site | Rank |
enmeguri.info |
equicareplus.com |
ero-movie-view.work |
erogazou.pw |
euro-surplus.jp |
everyavenuetravel.com |
exoblog.top |
expertmessage.cf |
fc108.jp |
fgoqge.com |
ppfze.com |
pradeepom.com |
US$3,488
Last updated: Nov 30, 2022
Elybiotech.com has global traffic rank of 23,958,535. Elybiotech.com has an estimated worth of US$ 3,488, based on its estimated Ads revenue. Elybiotech.com receives approximately 127 unique visitors each day. According to SiteAdvisor, elybiotech.com is unknown to visit. |
Purchase/Sale Value | US$3,488 |
Daily Ads Revenue | US$1 |
Monthly Ads Revenue | US$57 |
Yearly Ads Revenue | US$697 |
Daily Unique Visitors | 127 |
Note: All traffic and earnings values are estimates. |
Global Rank | 23,958,535 |
Delta (90 Days) | 0 |
Most Popular In Country | N/A |
Country Rank | N/A |
Host | Type | TTL | Data |
Domain Name: ELYBIOTECH.COM Registry Domain ID: 2564366866_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.apiname.com Registrar URL: http://www.atakdomain.com Updated Date: 2022-10-31T08:06:53Z Creation Date: 2020-10-07T14:02:34Z Registry Expiry Date: 2022-10-07T14:02:34Z Registrar: Atak Domain Bilgi Teknolojileri A.S. Registrar IANA ID: 1601 Registrar Abuse Contact Email: Registrar Abuse Contact Phone: Domain Status: clientHold https://icann.org/epp#clientHold Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Domain Status: redemptionPeriod https://icann.org/epp#redemptionPeriod Name Server: NS181.REDSERVERHOST.COM Name Server: NS182.REDSERVERHOST.COM DNSSEC: unsigned URL of the ICANN Whois Inaccuracy Complaint Form: https://www.icann.org/wicf/ DNA Whois Server V1.0 Whois server message delivered : 'request elybiotech.com' domain not found.. |